InvestorsHub Logo

learningcurve2020

06/23/21 8:55 AM

#7733 RE: n4807g #7732

And, all we get is a vague PR on the FDA issues with the trial. For all we know the trial never stood a chance from the very beginning. Just more research and OTC salaries.